logo
logo
Sign in

Hormone Replacement Therapy Market Research and Forecast by 2032

avatar
Ganesh Shinde
Hormone Replacement Therapy Market Research and Forecast by 2032

In 2032, the global Hormone Replacement Therapy Market is expected to reach US$ 12 billion, representing a yearly increase of 7.1%. The market saw robust growth between 2020 and 2022, fueled by the availability of long-acting hGH drugs and a higher prevalence of target disorders. The American Thyroid Association reports that about 12.0% of the US population will experience thyroid disease at some point in their lives, and approximately 20.0 million Americans currently suffer from thyroid illness.

A list of Key Players Covered in the Hormone Replacement Therapy Market Are:

  • Eli Lilly and Company
  • Pfizer, Inc.
  • AbbVie, Inc.
  • Novo Nordisk A/S
  • Merck KGaA
  • Mylan N.V.
  • Bayer Healthcare,
  • F. Hoffmann-La Roche Ltd.
  • Teva Pharmaceuticals,
  • Endo International,
  • Sun Pharmaceutical Industries Ltd,
  • Tolmar Pharmaceuticals, Inc.,
  • Novartis AG,
  • Upsher-Smith Laboratories Inc.,
  • SottoPelle,
  • Neuva Aesthetics,
  • Ascend Therapeutics

Menopause can cause several unpleasant symptoms for women, such as hot flashes and vaginal dryness. Hormone therapy, or menopausal hormone therapy, can be an effective treatment option by restoring hormone balance in the body. This has led to a projected surge in demand for hormone replacement therapy during the forecast period.

Additionally, the growing awareness of biological drugs for cancer treatment has contributed to the increased demand for hormone replacement therapy. The market for biologics and protein products has experienced significant growth due to advancements in analytics over the past two decades. Advanced analytical techniques allow for a more comprehensive analysis of complex protein molecules and drugs, aiding in the development of new therapies.

According to FMI, emerging countries like China and India present high growth opportunities for the hormone replacement therapy market. These regions are focusing on improving their healthcare infrastructure due to their increasing resources and large patient population. However, the lack of local manufacturers in these regions leads to higher costs as necessary medications are imported from developed regions. As a result, key players are expanding their manufacturing capacity to increase revenue from hormone replacement therapy.

Browse More@ https://www.futuremarketinsights.com/reports/hormone-replacement-therapy-market

Hormone Replacement Therapy Market: Segmentation

Based on Therapy Type:

  • Estrogen Replacement Therapy
  • Growth Hormone Replacement
  • Dopamine Agonist
  • Somatostatin Analogues
  • Thyroid Hormone Replacement
  • Tablets
  • Capsules
  • Injections

Based on Application:

  • Cancer
  • Menopause
  • Hypopituitarism
  • Hypothyroidism
  • Others

Based on Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies and Drugstores
  • Compounding Pharmacies
  • E-commerce
  • Others


collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more